Skip to Main Content
Our Commitment to Diversity

Modifier 25 and Same Day Services: How the Truth Finally Prevailed in a Recent Appeal, hosted by PYA

3rd Party Hosted Event
Date: 16 December 2021
Time: 11:00 AM ET
Location: via Webinar

The Office of the Inspector General maintains Modifier 25 as a target of its work plan each year. One of the types of reviews under Modifier 25 audits is chemotherapy infusion on the same day as an evaluation and management (E/M) service. Recovery audit contractors (RACs), Medicare Administrative Contractors (MACs), Unified Program Integrity Contractors (UPICs), and commercial payers often perform these audits as well. The U.S. Department of Justice has also reached settlements with providers on this topic. Many providers have fought and lost the battle as their E/M is denied due to the lack of supporting documentation above and beyond the chemotherapy infusion.

PYA Principal Valerie Rock will join Myla Reizen, a partner with K&L Gates, to discuss an administrative law judge’s recent appeal decision in which a practice was successful in overcoming denials—a rare occurrence.

In this one-hour webinar, Valerie and Myla will cover the background and tactics of this successful appeal strategy, including:

  • The history of the bundling of an E/M in the chemotherapy infusion.
  • Understanding what the common clinical reasoning is for performing an E/M during the period of treatment cycles.
  • Advancing your strategies as we take a deep dive into examples of a successful appeal and tactics applied.
  • PYA
Find more items tagged as: Health Care and FDA
Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel